Ceramides Mixture (Synonyms: 神经酰胺混合物)
目录号: PL11583 纯度: ≥98%
CAS No. :100403-19-8
商品编号 规格 价格 会员价 是否有货 数量
PL11583-25mg 25mg ¥2720.00 请登录
PL11583-50mg 50mg ¥4080.00 请登录
PL11583-100mg 100mg ¥6120.00 请登录
PL11583-200mg 200mg 询价 询价
PL11583-500mg 500mg 询价 询价
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Ceramides Mixture
中文别名
神经酰胺;5-氨基-3-溴-1-甲基吲唑;N-硬脂酰神经鞘氨醇;芦根提取物;神经酰胺(魔芋提取);神经酰胺-1;神经酰胺-2;神经酰胺-3;己酰基神经鞘氨醇;神经酰胺NP;神经酰胺混合物
英文名称
Ceramides Mixture
英文别名
Ceramide;Ceramides;Ceramides Mixture;Ceramide 6;Ceramide NP
Cas No.
100403-19-8
分子式
C46H82N2O23
分子量
1031.14
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
Ceramides Mixture 是一种内源性神经酰胺,由含羟基和非羟基脂肪酸的神经酰胺组成。Ceramides Mixture 是表皮渗透屏障的主要脂质成分。Ceramides Mixture 参与生长抑制,细胞周期停滞和端粒酶 (telomerase) 活性的调节。
生物活性
Ceramides Mixture is an endogenous ceramide and consists of hydroxy and non-hydroxy fatty acid-containing ceramides. Ceramides Mixture is a main lipid component of the permeability barrier in epidermis. Ceramides Mixture is involved in the regulation of growth inhibition, cell cycle arrest, and modulation of telomerase activity.
性状
Solid
体外研究(In Vitro)
Endogenous Ceramides (generated in response to bacterial sphingomyelinase overexpression or daunorubicin treatment) inhibits mRNA synthesis of telomerase reverse transcriptase and telomerase activity via inactivation of c-Myc transcription factor in the A549 human lung adenocarcinoma cell line.
The sustained generation of long chain endogenous ceramide requires the biochemical recycling of the sphingosine backbone of C6-ceramide, which involves deacylation and reacylation of ceramide for the generation of endogenous long chain ceramide (mainly C16:0- and C24:1-Ceramides), most likely by CoA-dependent ceramide synthase, which is inhibited by fumonisin B1. In A549 cells the generation of long chain endogenous ceramide mediates the effects of exogenous C6-ceramide on growth inhibition, cell cycle arrest, and the modulation of telomerase activity.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Ogretmen B, et al. Biochemical mechanisms of the generation of endogenous long chain ceramide in response to exogenous short chain ceramide in the A549 human lung adenocarcinoma cell line. Role for endogenous ceramide in mediating the action of exogenous ceramide. J Biol Chem. 2002 Apr 12;277(15):12960-9.
[2]. Macheleidt O, et al. Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. J Invest Dermatol. 2002 Jul;119(1):166-73.
溶解度数据
In Vitro: DMSO : 100 mg/mL (Need ultrasonic)H2O : 33.33 mg/mL (Need ultrasonic)Methanol : 25 mg/mL (Need ultrasonic)
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2